Skip to Content

AP4 (Iclusig 45 mg)

Generic Name: ponatinib

Pill with imprint AP4 is White, Round and has been identified as Iclusig 45 mg. It is supplied by ARIAD Pharmaceuticals, Inc..

Iclusig is used in the treatment of acute lymphoblastic leukemia; chronic myelogenous leukemia and belongs to the drug classes BCR-ABL tyrosine kinase inhibitors, multikinase inhibitors, VEGF/VEGFR inhibitors. There is positive evidence of human fetal risk during pregnancy. Iclusig 45 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for AP4

Iclusig

Generic Name:
ponatinib
Imprint:
AP4
Strength:
45 mg
Color:
White
Shape:
Round
Availability:
Prescription only
Drug Class:
BCR-ABL tyrosine kinase inhibitors
Multikinase inhibitors
VEGF/VEGFR inhibitors
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
ARIAD Pharmaceuticals, Inc.
National Drug Code (NDC):
76189-0534

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide